• ABL Diagnostics published its half-year financial report for the six months ended June 30, 2026.
• The filing was submitted to France’s AMF; interim financial statements were cleared by the board on Sept. 8, 2026.
• The statutory auditor reported no observations; limited review found no material misstatement.
• Posted at https://www.abldiagnostics.com under Newsroom, Legal and Financial News.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260930367594) on September 30, 2026, and is solely responsible for the information contained therein.